nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—type 2 diabetes mellitus—atherosclerosis	0.431	1	CtDrD
Pioglitazone—PPARG—atherosclerosis	0.17	1	CbGaD
Pioglitazone—SLCO1B3—Rosuvastatin—atherosclerosis	0.0388	0.13	CbGbCtD
Pioglitazone—SLCO1B3—Pravastatin—atherosclerosis	0.0353	0.119	CbGbCtD
Pioglitazone—SLCO1B1—Rosuvastatin—atherosclerosis	0.0226	0.0759	CbGbCtD
Pioglitazone—SLCO1B1—Ezetimibe—atherosclerosis	0.0226	0.0759	CbGbCtD
Pioglitazone—SLCO1B1—Simvastatin—atherosclerosis	0.021	0.0705	CbGbCtD
Pioglitazone—SLCO1B1—Lovastatin—atherosclerosis	0.0206	0.069	CbGbCtD
Pioglitazone—SLCO1B1—Pravastatin—atherosclerosis	0.0206	0.069	CbGbCtD
Pioglitazone—CYP2C8—Simvastatin—atherosclerosis	0.00889	0.0299	CbGbCtD
Pioglitazone—CYP2C8—Lovastatin—atherosclerosis	0.0087	0.0292	CbGbCtD
Pioglitazone—CYP2C8—Pravastatin—atherosclerosis	0.0087	0.0292	CbGbCtD
Pioglitazone—CYP2C19—Rosuvastatin—atherosclerosis	0.00802	0.0269	CbGbCtD
Pioglitazone—CYP2C19—Simvastatin—atherosclerosis	0.00746	0.025	CbGbCtD
Pioglitazone—CYP2C19—Lovastatin—atherosclerosis	0.0073	0.0245	CbGbCtD
Pioglitazone—CYP2D6—Niacin—atherosclerosis	0.00717	0.0241	CbGbCtD
Pioglitazone—CYP2C9—Rosuvastatin—atherosclerosis	0.00667	0.0224	CbGbCtD
Pioglitazone—CYP2C9—Simvastatin—atherosclerosis	0.0062	0.0208	CbGbCtD
Pioglitazone—CYP2C9—Lovastatin—atherosclerosis	0.00607	0.0204	CbGbCtD
Pioglitazone—CYP2C9—Pravastatin—atherosclerosis	0.00607	0.0204	CbGbCtD
Pioglitazone—CYP2D6—Simvastatin—atherosclerosis	0.00567	0.019	CbGbCtD
Pioglitazone—CYP2D6—Lovastatin—atherosclerosis	0.00555	0.0186	CbGbCtD
Pioglitazone—CYP2D6—Pravastatin—atherosclerosis	0.00555	0.0186	CbGbCtD
Pioglitazone—CYP3A4—Rosuvastatin—atherosclerosis	0.00388	0.013	CbGbCtD
Pioglitazone—CYP3A4—Ezetimibe—atherosclerosis	0.00388	0.013	CbGbCtD
Pioglitazone—CYP3A4—Simvastatin—atherosclerosis	0.0036	0.0121	CbGbCtD
Pioglitazone—CYP3A4—Pravastatin—atherosclerosis	0.00353	0.0118	CbGbCtD
Pioglitazone—CYP3A4—Lovastatin—atherosclerosis	0.00353	0.0118	CbGbCtD
Pioglitazone—Macular oedema—Niacin—atherosclerosis	0.00159	0.0278	CcSEcCtD
Pioglitazone—PPARG—leg—atherosclerosis	0.00147	0.15	CbGeAlD
Pioglitazone—PPARG—hindlimb—atherosclerosis	0.00131	0.134	CbGeAlD
Pioglitazone—Breast feeding—Simvastatin—atherosclerosis	0.00121	0.0212	CcSEcCtD
Pioglitazone—PPARG—appendage—atherosclerosis	0.00113	0.115	CbGeAlD
Pioglitazone—Breast feeding—Pravastatin—atherosclerosis	0.00109	0.0192	CcSEcCtD
Pioglitazone—PPARG—artery—atherosclerosis	0.000806	0.0819	CbGeAlD
Pioglitazone—Pregnancy—Lovastatin—atherosclerosis	0.000796	0.0139	CcSEcCtD
Pioglitazone—Blood creatine phosphokinase increased—Rosuvastatin—atherosclerosis	0.000775	0.0136	CcSEcCtD
Pioglitazone—Rosiglitazone—PPARG—atherosclerosis	0.000768	0.727	CrCbGaD
Pioglitazone—Pregnancy—Simvastatin—atherosclerosis	0.000745	0.013	CcSEcCtD
Pioglitazone—PPARG—endothelium—atherosclerosis	0.00068	0.0691	CbGeAlD
Pioglitazone—Blood creatine phosphokinase increased—Lovastatin—atherosclerosis	0.000656	0.0115	CcSEcCtD
Pioglitazone—Generalised oedema—Niacin—atherosclerosis	0.000652	0.0114	CcSEcCtD
Pioglitazone—Liver disorder—Ezetimibe—atherosclerosis	0.00065	0.0114	CcSEcCtD
Pioglitazone—Blood creatine phosphokinase increased—Ezetimibe—atherosclerosis	0.000644	0.0113	CcSEcCtD
Pioglitazone—PPARG—blood vessel—atherosclerosis	0.000628	0.0638	CbGeAlD
Pioglitazone—Liver disorder—Simvastatin—atherosclerosis	0.00062	0.0109	CcSEcCtD
Pioglitazone—Blood creatine phosphokinase increased—Simvastatin—atherosclerosis	0.000614	0.0108	CcSEcCtD
Pioglitazone—Respiratory tract infection—Pravastatin—atherosclerosis	0.000608	0.0106	CcSEcCtD
Pioglitazone—Proteinuria—Rosuvastatin—atherosclerosis	0.000607	0.0106	CcSEcCtD
Pioglitazone—Accidental injury—Rosuvastatin—atherosclerosis	0.000603	0.0106	CcSEcCtD
Pioglitazone—Protein urine present—Rosuvastatin—atherosclerosis	0.000598	0.0105	CcSEcCtD
Pioglitazone—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.000564	0.00987	CcSEcCtD
Pioglitazone—Liver disorder—Pravastatin—atherosclerosis	0.000561	0.00982	CcSEcCtD
Pioglitazone—Blood creatine phosphokinase increased—Pravastatin—atherosclerosis	0.000555	0.00972	CcSEcCtD
Pioglitazone—Accidental injury—Lovastatin—atherosclerosis	0.000511	0.00894	CcSEcCtD
Pioglitazone—Proteinuria—Simvastatin—atherosclerosis	0.000481	0.00842	CcSEcCtD
Pioglitazone—Protein urine present—Simvastatin—atherosclerosis	0.000474	0.00831	CcSEcCtD
Pioglitazone—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.000445	0.00779	CcSEcCtD
Pioglitazone—Gastroenteritis—Rosuvastatin—atherosclerosis	0.000437	0.00765	CcSEcCtD
Pioglitazone—PTGS1—artery—atherosclerosis	0.000431	0.0438	CbGeAlD
Pioglitazone—Hepatic failure—Rosuvastatin—atherosclerosis	0.000431	0.00754	CcSEcCtD
Pioglitazone—Injury—Rosuvastatin—atherosclerosis	0.000421	0.00737	CcSEcCtD
Pioglitazone—Fluid retention—Niacin—atherosclerosis	0.000368	0.00645	CcSEcCtD
Pioglitazone—Hepatic failure—Lovastatin—atherosclerosis	0.000365	0.00639	CcSEcCtD
Pioglitazone—PTGS1—endothelium—atherosclerosis	0.000364	0.037	CbGeAlD
Pioglitazone—Hepatic failure—Ezetimibe—atherosclerosis	0.000358	0.00627	CcSEcCtD
Pioglitazone—Injury—Lovastatin—atherosclerosis	0.000357	0.00625	CcSEcCtD
Pioglitazone—Cramps of lower extremities—Niacin—atherosclerosis	0.000356	0.00624	CcSEcCtD
Pioglitazone—Diabetes mellitus—Simvastatin—atherosclerosis	0.000353	0.00618	CcSEcCtD
Pioglitazone—Breast disorder—Rosuvastatin—atherosclerosis	0.00035	0.00612	CcSEcCtD
Pioglitazone—SLCO1B3—liver—atherosclerosis	0.000347	0.0353	CbGeAlD
Pioglitazone—Hepatic failure—Simvastatin—atherosclerosis	0.000341	0.00598	CcSEcCtD
Pioglitazone—Abnormal vision—Niacin—atherosclerosis	0.000338	0.00593	CcSEcCtD
Pioglitazone—PTGS1—blood vessel—atherosclerosis	0.000335	0.0341	CbGeAlD
Pioglitazone—Influenza—Rosuvastatin—atherosclerosis	0.000334	0.00586	CcSEcCtD
Pioglitazone—Pain in extremity—Lovastatin—atherosclerosis	0.000328	0.00574	CcSEcCtD
Pioglitazone—Diabetes mellitus—Niacin—atherosclerosis	0.000324	0.00567	CcSEcCtD
Pioglitazone—PPARG—connective tissue—atherosclerosis	0.000322	0.0327	CbGeAlD
Pioglitazone—Pain in extremity—Ezetimibe—atherosclerosis	0.000322	0.00563	CcSEcCtD
Pioglitazone—Bronchitis—Rosuvastatin—atherosclerosis	0.000322	0.00563	CcSEcCtD
Pioglitazone—Hepatic failure—Pravastatin—atherosclerosis	0.000309	0.0054	CcSEcCtD
Pioglitazone—Injury—Pravastatin—atherosclerosis	0.000302	0.00528	CcSEcCtD
Pioglitazone—Liver function test abnormal—Ezetimibe—atherosclerosis	0.000297	0.0052	CcSEcCtD
Pioglitazone—Breast disorder—Ezetimibe—atherosclerosis	0.000291	0.00509	CcSEcCtD
Pioglitazone—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00029	0.00508	CcSEcCtD
Pioglitazone—Rosiglitazone—ALB—atherosclerosis	0.000289	0.273	CrCbGaD
Pioglitazone—Haematuria—Rosuvastatin—atherosclerosis	0.000284	0.00498	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.000284	0.00497	CcSEcCtD
Pioglitazone—Influenza—Lovastatin—atherosclerosis	0.000283	0.00496	CcSEcCtD
Pioglitazone—PPARG—cardiovascular system—atherosclerosis	0.00028	0.0284	CbGeAlD
Pioglitazone—Sinusitis—Rosuvastatin—atherosclerosis	0.00028	0.0049	CcSEcCtD
Pioglitazone—Influenza—Ezetimibe—atherosclerosis	0.000278	0.00487	CcSEcCtD
Pioglitazone—Hepatitis—Rosuvastatin—atherosclerosis	0.000268	0.00469	CcSEcCtD
Pioglitazone—Pharyngitis—Rosuvastatin—atherosclerosis	0.000266	0.00465	CcSEcCtD
Pioglitazone—Erectile dysfunction—Lovastatin—atherosclerosis	0.000261	0.00457	CcSEcCtD
Pioglitazone—Liver function test abnormal—Niacin—atherosclerosis	0.00026	0.00455	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000258	0.00453	CcSEcCtD
Pioglitazone—Erectile dysfunction—Ezetimibe—atherosclerosis	0.000256	0.00448	CcSEcCtD
Pioglitazone—Liver function test abnormal—Pravastatin—atherosclerosis	0.000256	0.00448	CcSEcCtD
Pioglitazone—Bronchitis—Simvastatin—atherosclerosis	0.000255	0.00447	CcSEcCtD
Pioglitazone—Infestation—Ezetimibe—atherosclerosis	0.000248	0.00434	CcSEcCtD
Pioglitazone—Infestation NOS—Ezetimibe—atherosclerosis	0.000248	0.00434	CcSEcCtD
Pioglitazone—PPARG—adipose tissue—atherosclerosis	0.000247	0.0251	CbGeAlD
Pioglitazone—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000246	0.00432	CcSEcCtD
Pioglitazone—Urinary tract infection—Lovastatin—atherosclerosis	0.000246	0.0043	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000245	0.00428	CcSEcCtD
Pioglitazone—Erectile dysfunction—Simvastatin—atherosclerosis	0.000244	0.00428	CcSEcCtD
Pioglitazone—Influenza—Niacin—atherosclerosis	0.000243	0.00426	CcSEcCtD
Pioglitazone—Influenza—Pravastatin—atherosclerosis	0.00024	0.0042	CcSEcCtD
Pioglitazone—Angina pectoris—Niacin—atherosclerosis	0.000237	0.00415	CcSEcCtD
Pioglitazone—Sinusitis—Lovastatin—atherosclerosis	0.000237	0.00415	CcSEcCtD
Pioglitazone—Bronchitis—Niacin—atherosclerosis	0.000234	0.0041	CcSEcCtD
Pioglitazone—Angina pectoris—Pravastatin—atherosclerosis	0.000233	0.00409	CcSEcCtD
Pioglitazone—Sinusitis—Ezetimibe—atherosclerosis	0.000233	0.00407	CcSEcCtD
Pioglitazone—Flatulence—Rosuvastatin—atherosclerosis	0.00023	0.00402	CcSEcCtD
Pioglitazone—Hepatitis—Lovastatin—atherosclerosis	0.000227	0.00397	CcSEcCtD
Pioglitazone—Erectile dysfunction—Niacin—atherosclerosis	0.000224	0.00393	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000223	0.0039	CcSEcCtD
Pioglitazone—Hepatitis—Ezetimibe—atherosclerosis	0.000223	0.0039	CcSEcCtD
Pioglitazone—Sinusitis—Simvastatin—atherosclerosis	0.000222	0.00388	CcSEcCtD
Pioglitazone—Pharyngitis—Ezetimibe—atherosclerosis	0.000221	0.00387	CcSEcCtD
Pioglitazone—Erectile dysfunction—Pravastatin—atherosclerosis	0.000221	0.00387	CcSEcCtD
Pioglitazone—Oedema peripheral—Ezetimibe—atherosclerosis	0.000219	0.00384	CcSEcCtD
Pioglitazone—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000219	0.00383	CcSEcCtD
Pioglitazone—Weight increased—Pravastatin—atherosclerosis	0.000218	0.00382	CcSEcCtD
Pioglitazone—Weight decreased—Pravastatin—atherosclerosis	0.000217	0.0038	CcSEcCtD
Pioglitazone—Angioedema—Rosuvastatin—atherosclerosis	0.000213	0.00373	CcSEcCtD
Pioglitazone—Hepatitis—Simvastatin—atherosclerosis	0.000212	0.00372	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000211	0.00369	CcSEcCtD
Pioglitazone—Myocardial infarction—Pravastatin—atherosclerosis	0.00021	0.00367	CcSEcCtD
Pioglitazone—Sweating—Niacin—atherosclerosis	0.000208	0.00364	CcSEcCtD
Pioglitazone—Urinary tract infection—Pravastatin—atherosclerosis	0.000208	0.00364	CcSEcCtD
Pioglitazone—Immune system disorder—Ezetimibe—atherosclerosis	0.000201	0.00352	CcSEcCtD
Pioglitazone—SLCO1B1—liver—atherosclerosis	0.000201	0.0204	CbGeAlD
Pioglitazone—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000201	0.00351	CcSEcCtD
Pioglitazone—Sinusitis—Pravastatin—atherosclerosis	0.000201	0.00351	CcSEcCtD
Pioglitazone—Myalgia—Rosuvastatin—atherosclerosis	0.000198	0.00347	CcSEcCtD
Pioglitazone—Arthralgia—Rosuvastatin—atherosclerosis	0.000198	0.00347	CcSEcCtD
Pioglitazone—Hepatitis—Niacin—atherosclerosis	0.000195	0.00341	CcSEcCtD
Pioglitazone—Flatulence—Lovastatin—atherosclerosis	0.000195	0.00341	CcSEcCtD
Pioglitazone—Hypoaesthesia—Niacin—atherosclerosis	0.000194	0.0034	CcSEcCtD
Pioglitazone—Malnutrition—Ezetimibe—atherosclerosis	0.000194	0.00339	CcSEcCtD
Pioglitazone—Oedema peripheral—Niacin—atherosclerosis	0.000192	0.00336	CcSEcCtD
Pioglitazone—Hepatitis—Pravastatin—atherosclerosis	0.000192	0.00336	CcSEcCtD
Pioglitazone—Back pain—Lovastatin—atherosclerosis	0.000191	0.00335	CcSEcCtD
Pioglitazone—Hypoaesthesia—Pravastatin—atherosclerosis	0.000191	0.00334	CcSEcCtD
Pioglitazone—Flatulence—Ezetimibe—atherosclerosis	0.000191	0.00334	CcSEcCtD
Pioglitazone—Pharyngitis—Pravastatin—atherosclerosis	0.00019	0.00334	CcSEcCtD
Pioglitazone—Muscle spasms—Lovastatin—atherosclerosis	0.00019	0.00333	CcSEcCtD
Pioglitazone—Infection—Rosuvastatin—atherosclerosis	0.000189	0.00331	CcSEcCtD
Pioglitazone—Visual impairment—Niacin—atherosclerosis	0.000188	0.00329	CcSEcCtD
Pioglitazone—Back pain—Ezetimibe—atherosclerosis	0.000187	0.00328	CcSEcCtD
Pioglitazone—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000187	0.00327	CcSEcCtD
Pioglitazone—Muscle spasms—Ezetimibe—atherosclerosis	0.000186	0.00326	CcSEcCtD
Pioglitazone—Visual impairment—Pravastatin—atherosclerosis	0.000185	0.00324	CcSEcCtD
Pioglitazone—Ill-defined disorder—Lovastatin—atherosclerosis	0.000183	0.00321	CcSEcCtD
Pioglitazone—Eye disorder—Niacin—atherosclerosis	0.000182	0.00319	CcSEcCtD
Pioglitazone—Flatulence—Simvastatin—atherosclerosis	0.000182	0.00319	CcSEcCtD
Pioglitazone—Angioedema—Lovastatin—atherosclerosis	0.00018	0.00316	CcSEcCtD
Pioglitazone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00018	0.00315	CcSEcCtD
Pioglitazone—Anaemia—Ezetimibe—atherosclerosis	0.000179	0.00314	CcSEcCtD
Pioglitazone—Malaise—Lovastatin—atherosclerosis	0.000178	0.00312	CcSEcCtD
Pioglitazone—Cardiac disorder—Pravastatin—atherosclerosis	0.000178	0.00312	CcSEcCtD
Pioglitazone—Muscle spasms—Simvastatin—atherosclerosis	0.000178	0.00311	CcSEcCtD
Pioglitazone—Vertigo—Lovastatin—atherosclerosis	0.000177	0.00311	CcSEcCtD
Pioglitazone—Angioedema—Ezetimibe—atherosclerosis	0.000177	0.0031	CcSEcCtD
Pioglitazone—Malaise—Ezetimibe—atherosclerosis	0.000175	0.00306	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000173	0.00304	CcSEcCtD
Pioglitazone—PPARG—liver—atherosclerosis	0.000173	0.0176	CbGeAlD
Pioglitazone—Insomnia—Rosuvastatin—atherosclerosis	0.000172	0.00301	CcSEcCtD
Pioglitazone—PTGS1—connective tissue—atherosclerosis	0.000172	0.0175	CbGeAlD
Pioglitazone—Ill-defined disorder—Simvastatin—atherosclerosis	0.000171	0.003	CcSEcCtD
Pioglitazone—Anaemia—Simvastatin—atherosclerosis	0.000171	0.00299	CcSEcCtD
Pioglitazone—Malnutrition—Niacin—atherosclerosis	0.00017	0.00297	CcSEcCtD
Pioglitazone—Angioedema—Simvastatin—atherosclerosis	0.000169	0.00296	CcSEcCtD
Pioglitazone—Myalgia—Lovastatin—atherosclerosis	0.000168	0.00294	CcSEcCtD
Pioglitazone—Chest pain—Lovastatin—atherosclerosis	0.000168	0.00294	CcSEcCtD
Pioglitazone—Arthralgia—Lovastatin—atherosclerosis	0.000168	0.00294	CcSEcCtD
Pioglitazone—Hypertension—Ezetimibe—atherosclerosis	0.000167	0.00293	CcSEcCtD
Pioglitazone—Flatulence—Niacin—atherosclerosis	0.000167	0.00293	CcSEcCtD
Pioglitazone—Malaise—Simvastatin—atherosclerosis	0.000167	0.00292	CcSEcCtD
Pioglitazone—Discomfort—Lovastatin—atherosclerosis	0.000166	0.00291	CcSEcCtD
Pioglitazone—Vertigo—Simvastatin—atherosclerosis	0.000166	0.00291	CcSEcCtD
Pioglitazone—Arthralgia—Ezetimibe—atherosclerosis	0.000165	0.00289	CcSEcCtD
Pioglitazone—Chest pain—Ezetimibe—atherosclerosis	0.000165	0.00289	CcSEcCtD
Pioglitazone—Myalgia—Ezetimibe—atherosclerosis	0.000165	0.00289	CcSEcCtD
Pioglitazone—Flatulence—Pravastatin—atherosclerosis	0.000165	0.00288	CcSEcCtD
Pioglitazone—CYP2C9—cardiovascular system—atherosclerosis	0.000164	0.0167	CbGeAlD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000164	0.00287	CcSEcCtD
Pioglitazone—Muscle spasms—Niacin—atherosclerosis	0.000163	0.00286	CcSEcCtD
Pioglitazone—Discomfort—Ezetimibe—atherosclerosis	0.000163	0.00285	CcSEcCtD
Pioglitazone—Anaphylactic shock—Lovastatin—atherosclerosis	0.000161	0.00282	CcSEcCtD
Pioglitazone—Muscle spasms—Pravastatin—atherosclerosis	0.000161	0.00281	CcSEcCtD
Pioglitazone—Infection—Lovastatin—atherosclerosis	0.00016	0.0028	CcSEcCtD
Pioglitazone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000158	0.00277	CcSEcCtD
Pioglitazone—Arthralgia—Simvastatin—atherosclerosis	0.000157	0.00275	CcSEcCtD
Pioglitazone—Myalgia—Simvastatin—atherosclerosis	0.000157	0.00275	CcSEcCtD
Pioglitazone—Chest pain—Simvastatin—atherosclerosis	0.000157	0.00275	CcSEcCtD
Pioglitazone—Infection—Ezetimibe—atherosclerosis	0.000157	0.00275	CcSEcCtD
Pioglitazone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000157	0.00275	CcSEcCtD
Pioglitazone—Discomfort—Simvastatin—atherosclerosis	0.000155	0.00272	CcSEcCtD
Pioglitazone—Nervous system disorder—Ezetimibe—atherosclerosis	0.000155	0.00272	CcSEcCtD
Pioglitazone—Angioedema—Niacin—atherosclerosis	0.000155	0.00271	CcSEcCtD
Pioglitazone—Ill-defined disorder—Pravastatin—atherosclerosis	0.000155	0.00271	CcSEcCtD
Pioglitazone—Anaemia—Pravastatin—atherosclerosis	0.000154	0.0027	CcSEcCtD
Pioglitazone—Skin disorder—Ezetimibe—atherosclerosis	0.000154	0.00269	CcSEcCtD
Pioglitazone—Angioedema—Pravastatin—atherosclerosis	0.000153	0.00267	CcSEcCtD
Pioglitazone—Vertigo—Niacin—atherosclerosis	0.000152	0.00267	CcSEcCtD
Pioglitazone—Urticaria—Rosuvastatin—atherosclerosis	0.000151	0.00265	CcSEcCtD
Pioglitazone—Anaphylactic shock—Simvastatin—atherosclerosis	0.000151	0.00264	CcSEcCtD
Pioglitazone—Oedema—Simvastatin—atherosclerosis	0.000151	0.00264	CcSEcCtD
Pioglitazone—Malaise—Pravastatin—atherosclerosis	0.000151	0.00264	CcSEcCtD
Pioglitazone—Vertigo—Pravastatin—atherosclerosis	0.00015	0.00263	CcSEcCtD
Pioglitazone—Infection—Simvastatin—atherosclerosis	0.00015	0.00262	CcSEcCtD
Pioglitazone—PTGS1—cardiovascular system—atherosclerosis	0.00015	0.0152	CbGeAlD
Pioglitazone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000147	0.00257	CcSEcCtD
Pioglitazone—Insomnia—Lovastatin—atherosclerosis	0.000146	0.00255	CcSEcCtD
Pioglitazone—Myalgia—Niacin—atherosclerosis	0.000144	0.00253	CcSEcCtD
Pioglitazone—Arthralgia—Niacin—atherosclerosis	0.000144	0.00253	CcSEcCtD
Pioglitazone—Hypertension—Pravastatin—atherosclerosis	0.000144	0.00253	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000144	0.00252	CcSEcCtD
Pioglitazone—Dyspnoea—Lovastatin—atherosclerosis	0.000144	0.00252	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000143	0.00251	CcSEcCtD
Pioglitazone—Insomnia—Ezetimibe—atherosclerosis	0.000143	0.0025	CcSEcCtD
Pioglitazone—Arthralgia—Pravastatin—atherosclerosis	0.000142	0.00249	CcSEcCtD
Pioglitazone—Chest pain—Pravastatin—atherosclerosis	0.000142	0.00249	CcSEcCtD
Pioglitazone—Myalgia—Pravastatin—atherosclerosis	0.000142	0.00249	CcSEcCtD
Pioglitazone—Dyspnoea—Ezetimibe—atherosclerosis	0.000141	0.00247	CcSEcCtD
Pioglitazone—Discomfort—Pravastatin—atherosclerosis	0.00014	0.00246	CcSEcCtD
Pioglitazone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00014	0.00245	CcSEcCtD
Pioglitazone—Fatigue—Lovastatin—atherosclerosis	0.000139	0.00243	CcSEcCtD
Pioglitazone—Anaphylactic shock—Niacin—atherosclerosis	0.000138	0.00242	CcSEcCtD
Pioglitazone—Oedema—Niacin—atherosclerosis	0.000138	0.00242	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000137	0.00241	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000136	0.00239	CcSEcCtD
Pioglitazone—Asthenia—Rosuvastatin—atherosclerosis	0.000136	0.00239	CcSEcCtD
Pioglitazone—Insomnia—Simvastatin—atherosclerosis	0.000136	0.00239	CcSEcCtD
Pioglitazone—Oedema—Pravastatin—atherosclerosis	0.000136	0.00239	CcSEcCtD
Pioglitazone—Anaphylactic shock—Pravastatin—atherosclerosis	0.000136	0.00239	CcSEcCtD
Pioglitazone—Fatigue—Ezetimibe—atherosclerosis	0.000136	0.00239	CcSEcCtD
Pioglitazone—Infection—Pravastatin—atherosclerosis	0.000135	0.00237	CcSEcCtD
Pioglitazone—Skin disorder—Niacin—atherosclerosis	0.000134	0.00236	CcSEcCtD
Pioglitazone—Dyspnoea—Simvastatin—atherosclerosis	0.000134	0.00235	CcSEcCtD
Pioglitazone—Hyperhidrosis—Niacin—atherosclerosis	0.000134	0.00234	CcSEcCtD
Pioglitazone—Feeling abnormal—Lovastatin—atherosclerosis	0.000133	0.00233	CcSEcCtD
Pioglitazone—PTGS1—adipose tissue—atherosclerosis	0.000132	0.0134	CbGeAlD
Pioglitazone—Hyperhidrosis—Pravastatin—atherosclerosis	0.000132	0.00231	CcSEcCtD
Pioglitazone—CYP2C19—liver—atherosclerosis	0.000131	0.0133	CbGeAlD
Pioglitazone—Feeling abnormal—Ezetimibe—atherosclerosis	0.00013	0.00228	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00013	0.00228	CcSEcCtD
Pioglitazone—Diarrhoea—Rosuvastatin—atherosclerosis	0.00013	0.00228	CcSEcCtD
Pioglitazone—Fatigue—Simvastatin—atherosclerosis	0.00013	0.00228	CcSEcCtD
Pioglitazone—Urticaria—Lovastatin—atherosclerosis	0.000128	0.00224	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000126	0.00221	CcSEcCtD
Pioglitazone—Dizziness—Rosuvastatin—atherosclerosis	0.000126	0.0022	CcSEcCtD
Pioglitazone—Urticaria—Ezetimibe—atherosclerosis	0.000126	0.0022	CcSEcCtD
Pioglitazone—Insomnia—Niacin—atherosclerosis	0.000125	0.00219	CcSEcCtD
Pioglitazone—Feeling abnormal—Simvastatin—atherosclerosis	0.000124	0.00218	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000124	0.00218	CcSEcCtD
Pioglitazone—Dyspnoea—Niacin—atherosclerosis	0.000123	0.00216	CcSEcCtD
Pioglitazone—Insomnia—Pravastatin—atherosclerosis	0.000123	0.00216	CcSEcCtD
Pioglitazone—Dyspnoea—Pravastatin—atherosclerosis	0.000122	0.00213	CcSEcCtD
Pioglitazone—Urticaria—Simvastatin—atherosclerosis	0.00012	0.0021	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Niacin—atherosclerosis	0.00012	0.00209	CcSEcCtD
Pioglitazone—Headache—Rosuvastatin—atherosclerosis	0.000119	0.00209	CcSEcCtD
Pioglitazone—Hypersensitivity—Lovastatin—atherosclerosis	0.000119	0.00208	CcSEcCtD
Pioglitazone—Fatigue—Pravastatin—atherosclerosis	0.000118	0.00206	CcSEcCtD
Pioglitazone—Hypersensitivity—Ezetimibe—atherosclerosis	0.000116	0.00204	CcSEcCtD
Pioglitazone—Asthenia—Lovastatin—atherosclerosis	0.000116	0.00203	CcSEcCtD
Pioglitazone—CYP2C8—liver—atherosclerosis	0.000114	0.0116	CbGeAlD
Pioglitazone—Asthenia—Ezetimibe—atherosclerosis	0.000113	0.00199	CcSEcCtD
Pioglitazone—Feeling abnormal—Pravastatin—atherosclerosis	0.000112	0.00197	CcSEcCtD
Pioglitazone—Hypersensitivity—Simvastatin—atherosclerosis	0.000111	0.00195	CcSEcCtD
Pioglitazone—Diarrhoea—Lovastatin—atherosclerosis	0.00011	0.00193	CcSEcCtD
Pioglitazone—Urticaria—Niacin—atherosclerosis	0.00011	0.00193	CcSEcCtD
Pioglitazone—Urticaria—Pravastatin—atherosclerosis	0.000108	0.0019	CcSEcCtD
Pioglitazone—Asthenia—Simvastatin—atherosclerosis	0.000108	0.00189	CcSEcCtD
Pioglitazone—Diarrhoea—Ezetimibe—atherosclerosis	0.000108	0.00189	CcSEcCtD
Pioglitazone—Dizziness—Lovastatin—atherosclerosis	0.000107	0.00187	CcSEcCtD
Pioglitazone—Dizziness—Ezetimibe—atherosclerosis	0.000105	0.00183	CcSEcCtD
Pioglitazone—Diarrhoea—Simvastatin—atherosclerosis	0.000103	0.00181	CcSEcCtD
Pioglitazone—Hypersensitivity—Niacin—atherosclerosis	0.000102	0.00179	CcSEcCtD
Pioglitazone—CYP2C9—liver—atherosclerosis	0.000101	0.0103	CbGeAlD
Pioglitazone—Headache—Lovastatin—atherosclerosis	0.000101	0.00177	CcSEcCtD
Pioglitazone—Hypersensitivity—Pravastatin—atherosclerosis	0.0001	0.00176	CcSEcCtD
Pioglitazone—Dizziness—Simvastatin—atherosclerosis	9.97e-05	0.00175	CcSEcCtD
Pioglitazone—Asthenia—Niacin—atherosclerosis	9.93e-05	0.00174	CcSEcCtD
Pioglitazone—Headache—Ezetimibe—atherosclerosis	9.9e-05	0.00173	CcSEcCtD
Pioglitazone—Asthenia—Pravastatin—atherosclerosis	9.78e-05	0.00171	CcSEcCtD
Pioglitazone—Diarrhoea—Niacin—atherosclerosis	9.47e-05	0.00166	CcSEcCtD
Pioglitazone—Headache—Simvastatin—atherosclerosis	9.45e-05	0.00165	CcSEcCtD
Pioglitazone—Diarrhoea—Pravastatin—atherosclerosis	9.33e-05	0.00163	CcSEcCtD
Pioglitazone—Dizziness—Niacin—atherosclerosis	9.15e-05	0.0016	CcSEcCtD
Pioglitazone—Dizziness—Pravastatin—atherosclerosis	9.01e-05	0.00158	CcSEcCtD
Pioglitazone—Headache—Niacin—atherosclerosis	8.67e-05	0.00152	CcSEcCtD
Pioglitazone—Headache—Pravastatin—atherosclerosis	8.54e-05	0.0015	CcSEcCtD
Pioglitazone—CYP3A4—liver—atherosclerosis	7.73e-05	0.00785	CbGeAlD
Pioglitazone—CYP2D6—liver—atherosclerosis	7.61e-05	0.00773	CbGeAlD
Pioglitazone—SLCO1B1—Metabolism—APOB—atherosclerosis	5.24e-06	0.000156	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—BGN—atherosclerosis	5.12e-06	0.000153	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	5.12e-06	0.000153	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALOX15—atherosclerosis	5.1e-06	0.000152	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APOA2—atherosclerosis	5.1e-06	0.000152	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	5.1e-06	0.000152	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	5.1e-06	0.000152	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GSTM1—atherosclerosis	5.09e-06	0.000152	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.09e-06	0.000151	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—APOA5—atherosclerosis	5.07e-06	0.000151	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	5.05e-06	0.000151	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APOA2—atherosclerosis	5.05e-06	0.000151	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALOX15—atherosclerosis	5.05e-06	0.000151	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	5.05e-06	0.000151	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ABCG5—atherosclerosis	5.04e-06	0.00015	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—LPL—atherosclerosis	5e-06	0.000149	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—IL6—atherosclerosis	4.99e-06	0.000149	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ABCG5—atherosclerosis	4.99e-06	0.000149	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	4.99e-06	0.000149	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.92e-06	0.000147	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—ALB—atherosclerosis	4.88e-06	0.000145	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	4.88e-06	0.000145	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.88e-06	0.000145	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GPX1—atherosclerosis	4.88e-06	0.000145	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—LPA—atherosclerosis	4.86e-06	0.000145	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—HMOX1—atherosclerosis	4.86e-06	0.000145	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.83e-06	0.000144	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—LPA—atherosclerosis	4.82e-06	0.000144	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CG—atherosclerosis	4.8e-06	0.000143	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.78e-06	0.000142	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.77e-06	0.000142	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CD36—atherosclerosis	4.75e-06	0.000141	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NAMPT—atherosclerosis	4.74e-06	0.000141	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALOX5—atherosclerosis	4.71e-06	0.00014	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—BGN—atherosclerosis	4.71e-06	0.00014	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.71e-06	0.00014	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—LIPC—atherosclerosis	4.71e-06	0.00014	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—APOC3—atherosclerosis	4.68e-06	0.000139	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—NOS3—atherosclerosis	4.67e-06	0.000139	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—BGN—atherosclerosis	4.67e-06	0.000139	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APOA5—atherosclerosis	4.66e-06	0.000139	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—APOB—atherosclerosis	4.66e-06	0.000139	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—LDLR—atherosclerosis	4.65e-06	0.000138	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	4.64e-06	0.000138	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APOA5—atherosclerosis	4.62e-06	0.000138	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—AKT1—atherosclerosis	4.61e-06	0.000137	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—INS—atherosclerosis	4.55e-06	0.000135	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CETP—atherosclerosis	4.54e-06	0.000135	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GSTM1—atherosclerosis	4.53e-06	0.000135	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—MTHFR—atherosclerosis	4.5e-06	0.000134	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.49e-06	0.000134	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	4.49e-06	0.000134	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	4.45e-06	0.000133	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—LPL—atherosclerosis	4.45e-06	0.000132	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PPARA—atherosclerosis	4.42e-06	0.000132	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.4e-06	0.000131	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.36e-06	0.00013	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.36e-06	0.00013	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.35e-06	0.00013	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—SCARB1—atherosclerosis	4.35e-06	0.00013	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GPX1—atherosclerosis	4.34e-06	0.000129	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALOX5—atherosclerosis	4.34e-06	0.000129	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALOX5—atherosclerosis	4.3e-06	0.000128	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—AGT—atherosclerosis	4.28e-06	0.000127	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTGS2—atherosclerosis	4.27e-06	0.000127	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.23e-06	0.000126	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NAMPT—atherosclerosis	4.23e-06	0.000126	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CD36—atherosclerosis	4.23e-06	0.000126	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.2e-06	0.000125	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—LIPC—atherosclerosis	4.2e-06	0.000125	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCG1—atherosclerosis	4.2e-06	0.000125	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—APOE—atherosclerosis	4.19e-06	0.000125	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—APOC3—atherosclerosis	4.18e-06	0.000124	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ALB—atherosclerosis	4.17e-06	0.000124	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CAV1—atherosclerosis	4.15e-06	0.000124	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—LDLR—atherosclerosis	4.15e-06	0.000124	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—APOA1—atherosclerosis	4.14e-06	0.000123	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—HMGCR—atherosclerosis	4.11e-06	0.000122	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CETP—atherosclerosis	4.05e-06	0.000121	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—MTHFR—atherosclerosis	4e-06	0.000119	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—NOS3—atherosclerosis	3.99e-06	0.000119	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.97e-06	0.000118	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—FABP4—atherosclerosis	3.95e-06	0.000118	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—LCAT—atherosclerosis	3.95e-06	0.000118	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PPARA—atherosclerosis	3.93e-06	0.000117	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NAMPT—atherosclerosis	3.89e-06	0.000116	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SCARB1—atherosclerosis	3.88e-06	0.000116	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOA4—atherosclerosis	3.87e-06	0.000115	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—LIPC—atherosclerosis	3.86e-06	0.000115	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NAMPT—atherosclerosis	3.86e-06	0.000115	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APOC3—atherosclerosis	3.84e-06	0.000114	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.83e-06	0.000114	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—LIPC—atherosclerosis	3.83e-06	0.000114	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—LDLR—atherosclerosis	3.82e-06	0.000114	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APOC3—atherosclerosis	3.81e-06	0.000113	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP7A1—atherosclerosis	3.8e-06	0.000113	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AGT—atherosclerosis	3.8e-06	0.000113	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—LDLR—atherosclerosis	3.78e-06	0.000113	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	3.78e-06	0.000113	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.78e-06	0.000113	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CETP—atherosclerosis	3.73e-06	0.000111	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—APOE—atherosclerosis	3.73e-06	0.000111	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.7e-06	0.00011	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CETP—atherosclerosis	3.7e-06	0.00011	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CAV1—atherosclerosis	3.69e-06	0.00011	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—APOA1—atherosclerosis	3.68e-06	0.00011	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—HMGCR—atherosclerosis	3.67e-06	0.000109	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ABCA1—atherosclerosis	3.66e-06	0.000109	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PPARG—atherosclerosis	3.65e-06	0.000109	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTGS2—atherosclerosis	3.65e-06	0.000109	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—INS—atherosclerosis	3.58e-06	0.000107	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SCARB1—atherosclerosis	3.57e-06	0.000106	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SCARB1—atherosclerosis	3.54e-06	0.000105	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP27A1—atherosclerosis	3.52e-06	0.000105	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MAPK3—atherosclerosis	3.49e-06	0.000104	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.45e-06	0.000103	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HMGCR—atherosclerosis	3.37e-06	0.0001	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CG—atherosclerosis	3.36e-06	0.0001	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HMGCR—atherosclerosis	3.34e-06	9.96e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	3.33e-06	9.93e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	3.33e-06	9.93e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALOX15—atherosclerosis	3.33e-06	9.93e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOA2—atherosclerosis	3.33e-06	9.93e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.31e-06	9.85e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCG5—atherosclerosis	3.29e-06	9.81e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ALB—atherosclerosis	3.28e-06	9.78e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ABCA1—atherosclerosis	3.27e-06	9.73e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PPARG—atherosclerosis	3.25e-06	9.67e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—INS—atherosclerosis	3.18e-06	9.49e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—LPA—atherosclerosis	3.18e-06	9.47e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—HMOX1—atherosclerosis	3.14e-06	9.36e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—NOS3—atherosclerosis	3.14e-06	9.35e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—BGN—atherosclerosis	3.08e-06	9.17e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOA5—atherosclerosis	3.05e-06	9.08e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.01e-06	8.98e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—APOB—atherosclerosis	3.01e-06	8.96e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ABCA1—atherosclerosis	3.01e-06	8.95e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ABCA1—atherosclerosis	2.98e-06	8.87e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.93e-06	8.74e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTM1—atherosclerosis	2.93e-06	8.72e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ALB—atherosclerosis	2.92e-06	8.7e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—LPL—atherosclerosis	2.87e-06	8.56e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTGS2—atherosclerosis	2.87e-06	8.55e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.83e-06	8.44e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—HMOX1—atherosclerosis	2.8e-06	8.35e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GPX1—atherosclerosis	2.8e-06	8.35e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—NOS3—atherosclerosis	2.79e-06	8.32e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CD36—atherosclerosis	2.73e-06	8.13e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—APOB—atherosclerosis	2.69e-06	8e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTM1—atherosclerosis	2.61e-06	7.78e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—MTHFR—atherosclerosis	2.59e-06	7.7e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HMOX1—atherosclerosis	2.58e-06	7.68e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—LPL—atherosclerosis	2.56e-06	7.64e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HMOX1—atherosclerosis	2.56e-06	7.61e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTGS2—atherosclerosis	2.55e-06	7.61e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.54e-06	7.57e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPARA—atherosclerosis	2.54e-06	7.56e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—LIPC—atherosclerosis	2.53e-06	7.53e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOC3—atherosclerosis	2.51e-06	7.48e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GPX1—atherosclerosis	2.5e-06	7.45e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—LDLR—atherosclerosis	2.5e-06	7.43e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APOB—atherosclerosis	2.47e-06	7.36e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AGT—atherosclerosis	2.46e-06	7.32e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APOB—atherosclerosis	2.45e-06	7.29e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CETP—atherosclerosis	2.44e-06	7.26e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CD36—atherosclerosis	2.44e-06	7.26e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—APOE—atherosclerosis	2.41e-06	7.17e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTM1—atherosclerosis	2.4e-06	7.16e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CAV1—atherosclerosis	2.39e-06	7.11e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTM1—atherosclerosis	2.38e-06	7.09e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—APOA1—atherosclerosis	2.38e-06	7.09e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—LPL—atherosclerosis	2.36e-06	7.02e-05	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—AKT1—atherosclerosis	2.36e-06	7.02e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—LPL—atherosclerosis	2.34e-06	6.96e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.33e-06	6.95e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—MTHFR—atherosclerosis	2.31e-06	6.88e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GPX1—atherosclerosis	2.3e-06	6.85e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GPX1—atherosclerosis	2.28e-06	6.79e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPARA—atherosclerosis	2.26e-06	6.75e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CD36—atherosclerosis	2.24e-06	6.67e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CD36—atherosclerosis	2.22e-06	6.62e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.2e-06	6.57e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AGT—atherosclerosis	2.19e-06	6.53e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CG—atherosclerosis	2.17e-06	6.47e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—APOE—atherosclerosis	2.15e-06	6.4e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—AKT1—atherosclerosis	2.15e-06	6.4e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CAV1—atherosclerosis	2.13e-06	6.34e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—APOA1—atherosclerosis	2.12e-06	6.33e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—MTHFR—atherosclerosis	2.12e-06	6.32e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—MTHFR—atherosclerosis	2.1e-06	6.27e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPARG—atherosclerosis	2.1e-06	6.25e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPARA—atherosclerosis	2.08e-06	6.2e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPARA—atherosclerosis	2.06e-06	6.15e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—INS—atherosclerosis	2.06e-06	6.13e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AGT—atherosclerosis	2.02e-06	6.01e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AGT—atherosclerosis	2e-06	5.96e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APOE—atherosclerosis	1.98e-06	5.89e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.96e-06	5.85e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APOE—atherosclerosis	1.96e-06	5.84e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CAV1—atherosclerosis	1.96e-06	5.83e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APOA1—atherosclerosis	1.95e-06	5.82e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CAV1—atherosclerosis	1.94e-06	5.78e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CG—atherosclerosis	1.94e-06	5.78e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APOA1—atherosclerosis	1.94e-06	5.77e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALB—atherosclerosis	1.89e-06	5.62e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPARG—atherosclerosis	1.87e-06	5.58e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—INS—atherosclerosis	1.84e-06	5.47e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—AKT1—atherosclerosis	1.83e-06	5.46e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NOS3—atherosclerosis	1.8e-06	5.37e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.78e-06	5.31e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CG—atherosclerosis	1.77e-06	5.27e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPARG—atherosclerosis	1.72e-06	5.13e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPARG—atherosclerosis	1.71e-06	5.08e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—INS—atherosclerosis	1.69e-06	5.03e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.69e-06	5.02e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALB—atherosclerosis	1.68e-06	5.01e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—INS—atherosclerosis	1.67e-06	4.99e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTGS2—atherosclerosis	1.65e-06	4.91e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOB—atherosclerosis	1.61e-06	4.81e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NOS3—atherosclerosis	1.61e-06	4.8e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.57e-06	4.68e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALB—atherosclerosis	1.55e-06	4.61e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—LPL—atherosclerosis	1.54e-06	4.59e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALB—atherosclerosis	1.53e-06	4.57e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GPX1—atherosclerosis	1.5e-06	4.48e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NOS3—atherosclerosis	1.48e-06	4.41e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTGS2—atherosclerosis	1.47e-06	4.39e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NOS3—atherosclerosis	1.47e-06	4.37e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CD36—atherosclerosis	1.46e-06	4.36e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—AKT1—atherosclerosis	1.44e-06	4.3e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.39e-06	4.14e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPARA—atherosclerosis	1.36e-06	4.06e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.35e-06	4.03e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.34e-06	4e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AGT—atherosclerosis	1.32e-06	3.93e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOE—atherosclerosis	1.29e-06	3.85e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AKT1—atherosclerosis	1.28e-06	3.82e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CAV1—atherosclerosis	1.28e-06	3.81e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOA1—atherosclerosis	1.28e-06	3.81e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.17e-06	3.47e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPARG—atherosclerosis	1.13e-06	3.35e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—INS—atherosclerosis	1.1e-06	3.29e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALB—atherosclerosis	1.01e-06	3.02e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NOS3—atherosclerosis	9.68e-07	2.88e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS2—atherosclerosis	8.86e-07	2.64e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AKT1—atherosclerosis	8.29e-07	2.47e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AKT1—atherosclerosis	7.4e-07	2.2e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AKT1—atherosclerosis	6.81e-07	2.03e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AKT1—atherosclerosis	6.75e-07	2.01e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKT1—atherosclerosis	4.45e-07	1.33e-05	CbGpPWpGaD
